A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma

Caroline E. Nunes‐Xavier(BioCruces Health research Institute), José I. López(BioCruces Health research Institute), J.C. Angulo(Hospital Universitario de Getafe), Rafael Pulido(Instituto Valenciano de Investigaciones Agrarias)

Current Urology Reports

January 1, 2019

10.1007/s11934-019-0866-8

Cited by 70

Related Papers

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

|Cell|2018|883

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

|Cell|2018|680

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

|Cell|2018|565

Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth

|Cancer Cell|2011|544

PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif

|The EMBO Journal|1998|314